GI & Endoscopy

Laval, Canada-based Valeant Pharmaceuticals is entering a free fall, Business Insider reports.

Charles Barish, MD, is a gastroenterologist at Raleigh, N.C.-based Wake Gastroenterology.

A study in Cancer Medicine found that a new blood test is more sensitive than a standard carcinoembryonic antigen test when identifying colorectal cancer recurrence.

Peyton P. Berookim, MD, is a gastroenterologist and the director of the Los Angeles-based Gastroenterology Institute of Southern California.

Leverkusen, Germany-based Bayer submitted a new drug application to the FDA for Stivarga or Regorafenib, its second-line treatment for liver cancer patients, Tech Times reports.

Osaka, Japan-based Takeda Pharmaceuticals and New York City-based technology company Koneksa Health have partnered to integrate digital health tools into early-stage clinical trials.

Rani Richardson has been named the 2016 American Gastroenterological Association Investing in the Future Student Research Fellowship Award recipient.

Mitchell Bernsen, MD, is a gastroenterologist with Illinois Gastroenterology Group.

Jerusalem, Israel-based Immunovative Therapies is starting a phase IIb clinical trial for CryoVax, an immunotherapy cancer vaccine for patients with chemotherapy-refractory metastatic colorectal cancer.

Here are the five most popular Becker's ASC Review gastroenterology and endoscopy stories for the week of Oct. 31 to Nov. 4.